ILC Therapeutics
Medical Incubator Japan targets further UK healthcare investments in 2021
Medical Incubator Japan (MIJ), an independent venture capital fund investing in early-stage life sciences companies, is planning further UK healthcare investments in 2021 after completing two landmark UK investments in 2020.
Published 3 March 2021

ILC Therapeutics announces first international investor
Lanarkshire-based biotechnology company ILC Therapeutics (ILCT) has announced that it has secured significant investment from its first global investor Medical Incubator Japan (MIJ).
Published 1 December 2020
